Gefitinib IP Tablets 250mg

Product Description

Gefitinib IP Tablets 250mg are a targeted anticancer therapy used in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). The medication works by inhibiting the activity of specific receptors that promote cancer cell growth, especially in patients with EGFR gene mutations.

Product Overview

Product Name: Gefitinib IP Tablets 250mg
Product Form: Tablets
Pack Size: 30's
Manufactured By: MBA Pharmaceuticals
Used For: Treatment of advanced or metastatic non-small cell lung cancer with EGFR mutations
Prescription Required: Yes

How It Works

Gefitinib inhibits the epidermal growth factor receptor (EGFR), a protein that plays a key role in cancer cell growth and survival. In NSCLC patients with EGFR mutations, this receptor becomes overactive, leading to uncontrolled cancer progression. By blocking EGFR signaling, Gefitinib helps slow tumor growth, reduce cancer spread, and improve symptoms related to lung function.

Key Benefits

Helps treat EGFR-mutated non-small cell lung cancer.
Slows tumor growth and reduces cancer spread.
Targets specific pathways involved in cancer cell development.
Improves breathing, reduces cough, and enhances overall comfort in advanced lung cancer patients.

How to Use

Take Gefitinib IP Tablets exactly as prescribed by your oncologist.
Typically taken once daily with or without food.
Swallow the tablet whole and avoid crushing or breaking it.

Side Effects and Precautions

Common Side Effects

Diarrhea
Skin rash, dryness, or itching
Nausea and vomiting
Fatigue or weakness
Loss of appetite
Dry mouth
Liver function abnormalities such as elevated enzymes or jaundice

Serious Side Effects

Interstitial lung disease (ILD), which may cause cough, breathing difficulty, and lung inflammation

Precautions

Regular liver function monitoring is recommended during treatment.
Inform your doctor about all medications and supplements to avoid drug interactions.
Not recommended during pregnancy or breastfeeding.
Monitor for respiratory symptoms and discontinue use if ILD develops.
Use with caution in patients with renal impairment, and monitor kidney function as needed.

Who Should Use

Patients diagnosed with EGFR-positive advanced or metastatic non-small cell lung cancer and prescribed this therapy by an oncology specialist.

Storage Instructions

Store in a cool, dry place away from direct sunlight.
Keep out of reach of children and ensure the medication is used before expiry.

Disclaimer

This medication must be used under medical supervision. The information provided does not replace professional medical advice. Always consult your doctor for diagnosis, treatment planning, and correct dosing instructions.